Financial Crime World

Blowing the Whistle on Financial Crimes: BNP Paribas Hong Kong’s Compliance System

BNP Paribas, a leading international banking group, is committed to upholding integrity and transparency in its Hong Kong operations. In line with this commitment, the bank has established a robust whistleblowing system to report suspected violations of laws and the Group Code of Conduct.

Robust Whistleblowing System in BNP Paribas Hong Kong

BNP Paribas’s entities in Hong Kong offer a secure and confidential channel for reporting actual or suspected illegal activities. This system is not meant for processing client complaints, which are handled separately.

Protecting Whistleblowers

BNP Paribas Hong Kong’s commitment to upholding integrity and transparency extends to protecting whistleblowers from retaliation. Local applicable laws shield whistleblowers from retaliation. Anyone who misuses the whistleblowing system may face disciplinary actions or legal consequences.

Reporting Illegitimate Activities

Employees, external parties, and former employees, including suppliers and their sub-contractors, can report the following infractions:

  • Corruption and influence peddling
  • Fraud
  • Violations of professional ethics
  • Infringements of rules for the protection of clients
  • Unauthorized communication of confidential information
  • Human rights abuses and environmental damage
  • Serious violations of policies regarding suppliers and social media use

Reporting Procedure

To report any violation, you can contact BNP Paribas Hong Kong via:

  • Phone: +852-2909-8555
  • Email: whistle-blowing.hk@asia.bnpparibas.com
  • Postal address: 8/F, Lincoln House, Taikoo Place, 979 King’s Road, Quarry Bay, Hong Kong Attn: Head of Compliance, Greater China

When reporting, please provide accurate and relevant information, including documents, to support the allegations. All reports are kept confidential. Only select individuals are privy to the whistleblower’s identity, the targeted person(s), and any other named parties, as required for investigative purposes.